Ghanima, W., Demerdash, D. E., Frederiksen, H., Bussel, J., Tsykunova, G., Michel, M., Tran, H., Nassar, C., Darne, B., Tjønnfjord, E., Tvedt, T. H., M'Sadek, F., Mattar, M., Khelif, A., Holme, P. (2025). The prolong trial: A two Phase randomized placebo-controlled trial to optimize rituximab response with dexamethasone and maintenance therapy with low dose rituximab in immune thrombocytopenia (ITP) patients. Blood. https://doi.org/10.1182/blood-2025-736